title: Hepatic arterial infusion of oxaliplatin, 5-fluorouracil and leucovorin in patients  with liver metastases from colorectal carcinoma.
abstract: OBJECTIVE
  Limited data are available regarding the efficacy of hepatic arterial infusion (HAI) of oxaliplatin in patients with liver metastases from colorectal carcinoma (CRC). The aim of the present study was to evaluate the results of HAI of oxaliplatin combined with 5-fluorouracil (5-FU) and leucovorin (LV) in patients with such metastases.
  
  
  METHODS
  A retrospective analysis of 22 CRC patients treated with HAI of combination of oxaliplatin and 5-FU and LV was performed.
  
  
  RESULTS
  Partial response (PR) was observed in 4 (18%) patients and stable disease (SD) in 7, with an overall disease control rate of 50%. The median progression-free (PFS) and overall survival (OS) were 7 and 11 months, respectively. Two patients treated with first-line treatment underwent subsequent liver resection. In 2 patients, HAI of oxaliplatin, 5-FU and LV was combined with systemic administration of bevacizumab.
  
  
  CONCLUSIONS
  Our data demonstrate reasonable efficacy of HAI with oxaliplatin, 5-FU and LV in patients with liver metastases from CRC.
authors: Department of Oncology, Palacký University Medical School & Teaching Hospital, Olomouc, Czech Republic. bohuslav.melichar@fnol.cz
authors: B
authors: B
authors: Melichar
authors: A
authors: A
authors: Ferko
authors: A
authors: A
authors: Krajina
authors: L
authors: L
authors: Rousková
authors: J
authors: J
authors: Dvorák
authors: H
authors: H
authors: Svébisova
authors: C
authors: C
authors: Neoral
authors: M
authors: M
authors: Köcher
authors: E
authors: E
authors: Malirová
authors: J
authors: J
authors: Paral
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage*; D002272:Carcinoembryonic Antigen / Q000097:blood; D015179:Colorectal Neoplasms / Q000473:pathology*; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D006499:Hepatic Artery; D006801:Humans; D007261:Infusions, Intra-Arterial; D002955:Leucovorin / Q000008:administration & dosage; D008113:Liver Neoplasms / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009944:Organoplatinum Compounds / Q000008:administration & dosage; D000077150:Oxaliplatin; D012189:Retrospective Studies
chemical_list: D002272:Carcinoembryonic Antigen; D009944:Organoplatinum Compounds; D000077150:Oxaliplatin; D002955:Leucovorin; D005472:Fluorouracil